Four members of the Department have received significant honors recently. Professor Gillian Griffiths (Division of Immunology and Director of CIMR) was elected to Fellowship of the Royal Society. Dr David Jayne (Consultant in Nephrology and Vasculitis), Professor Sharon Peacock (Professor of Clinical Microbiology) and Professor KJ Patel (Group leader and member of scientific staff at […]
Reactivation of latent human cytomegalovirus (HCMV) infection following transplantation is associated with high morbidity and mortality; yet current therapies for HCMV, which target virus replicating productively, will not target latent viral genomes. There is also increasing evidence that HCMV persistence is associated with long-term diseases such as atherosclerosis, chronic graft rejection and neoplasias and, in […]
Dr Murray Clarke has been awarded a British Heart Foundation Senior Research Fellowship to investigate how cell type-specific necrosis drives inflammation in atherosclerosis and other chronic inflammatory diseases. Murray Clarke has previously shown that death of vascular smooth muscle cells (VSMCs) leads to unstable atherosclerotic plaques – the primary cause of heart attacks and stroke. […]
Can whole genome sequencing provide the forensic information needed to map and control the global spread of antibiotic-resistant bacteria?
Although anti-HIV drugs can significantly prolong life, patients must take the drugs for the rest of their lives. New approaches to therapeutics may hold the answer to finding a cure for HIV.
A team from Cambridge University which included member of the Dept of Medicine has won the £1,000 top prize in the annual contest co-organised by the Biotechnology and Biological Sciences Research Council (BBSRC) and the University of Nottingham Institute for Enterprise and Innovation (UNIEI). Photograph copyright to Tim Gander 2012.
Scientists have discovered a patient-friendly and efficient way to make stem cells out of blood, increasing the hope that scientists could one day use stem cells made from patients’ own cells to treat cardiovascular disease. Their research was published today in the journal Stem Cells: Translational Medicine.
For the first time, researchers have used DNA sequencing to help bring an infectious disease outbreak in a hospital to a close. Researchers from the the University of Cambridge, the Wellcome Trust Sanger Institute, and Cambridge University Hospitals used advanced DNA sequencing technologies to confirm the presence of an ongoing outbreak of methicillin-resistant Staphylococcus aureus […]
A drug which ‘reboots’ a person’s immune system has been shown to be an effective treatment for multiple sclerosis (MS) patients who have already failed to respond to the first drug with which they were treated (a ‘first-line’ therapy), as well as affected individuals who were previously untreated. The results of these two phase III […]
Fundraising is under way for a joint Cambridge University and Papworth Hospital Heart and Lung Research Institute – to sit alongside the anticipated new Papworth Hospital on the Cambridge Biomedical Campus – enabling a major expansion of cardiorespiratory research in Cambridge. Plans (subject to final design selection) of the Heart and Lung Research Institute […]